文献速递骨软组织肉瘤与黑色素瘤

葡萄膜黑色素瘤腹膜转移患者的特征分析:一项回顾性单中心研究

Characterizing uveal melanoma patients with peritoneal metastases: A retrospective single-center analysis.
PubMed 文献 · Eur J Cancer · 2025-02-06

该回顾性单中心分析纳入柏林夏里特大学医学院数据库中41例确诊腹膜转移的转移性葡萄膜黑色素瘤患者,分析临床特征、免疫细胞浸润、基因改变和肿瘤突变负荷。结果显示腹膜转移发生率为4.27%,诊断转移性葡萄膜黑色素瘤后中位总生存为22.4个月,预后与转移模式相关;仅肝外病变者中位总生存达48.6个月,且该转移模式与低/中遗传风险高度显著相关。

要点

  • 转移性葡萄膜黑色素瘤中腹膜转移发生率为4.27%。
  • 诊断转移性葡萄膜黑色素瘤后中位总生存为22.4个月。
  • 仅肝外病变者中位总生存48.6个月,该模式与低/中遗传风险高度显著相关。

核心结论

  • 转移性葡萄膜黑色素瘤患者的腹膜转移罕见,且与其他腹外肿瘤不同,并不使预后恶化。
  • 预后很大程度上受转移模式影响,而转移模式由肿瘤生物学决定,证据为其与遗传风险组和肿瘤突变负荷的相关性。

研究设计与样本

  • 回顾性单中心分析,纳入柏林夏里特大学医学院数据库中41例确诊腹膜转移的转移性葡萄膜黑色素瘤患者。
  • 分析内容聚焦临床特征、免疫细胞浸润、基因改变和肿瘤突变负荷。

主要发现

  • 转移性葡萄膜黑色素瘤中腹膜转移的发生率为4.27%。
  • 原发葡萄膜黑色素瘤诊断后3.6年诊断转移性疾病,腹膜转移出现更晚(中位4.7年)。
  • 诊断转移性葡萄膜黑色素瘤后中位总生存为22.4个月。
  • 同时存在肝和腹膜转移者中位总生存为19.7个月,原发肝转移后继发腹膜播散者中位总生存为17.7个月。
  • 诊断转移性葡萄膜黑色素瘤时仅有肝外病变的腹膜转移患者中位总生存为48.6个月,显著更长,且该转移模式与低和中遗传风险高度显著相关;高危葡萄膜黑色素瘤患者的无转移生存和诊断转移性葡萄膜黑色素瘤后的总生存显著更短;肿瘤突变负荷与转移模式相关,仅在肝外病变者中最低,较高的肿瘤突变负荷总体与较短的总生存相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Metastatic uveal melanoma (mUM) is an aggressive cancer predominately affecting the liver. Peritoneal metastases (PM) occur rarely, and there is limited knowledge about this subgroup´s clinical course and biology. METHODS: We analyzed 41 mUM patients with confirmed PM from the Charité-Universitätsmedizin Berlin database, focusing on clinical characteristics, immune cell infiltrates, genetic alterations and tumor mutational burden (TMB). RESULTS: The incidence of PM in mUM was 4.27 %. Metastatic disease was diagnosed 3.6 years after primary UM, with PM developing later (median: 4.7 years). Median overall survival (OS) from mUM diagnosis was 22.4 months. Prognosis correlated with metastatic pattern. Patients presenting with synchronous liver and peritoneal metastases or primary hepatic metastases followed by secondary peritoneal dissemination showed a median OS of 19.7 and 17.7 months, respectively. However, PM patients with exclusive extrahepatic disease at diagnosis of mUM had a significantly longer OS of 48.6 months and this metastatic pattern showed highly significant correlation with low and intermediate genetic risk. Metastasis-free survival and OS upon mUM diagnosis were significantly shorter in patients with high-risk UM tumors. TMB also correlated with metastatic pattern, being lowest in patients presenting with only extrahepatic disease. Higher TMB was generally associated with shorter OS. CONCLUSION: PM in mUM patients is rare and in contrast to other extra-abdominal tumors does not worsen prognosis. Prognosis is greatly influenced by the metastatic pattern, which is determined by tumor biology, as evidenced by its correlation with genetic risk groups and TMB.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Rosnev S, Peuker CA, Piwonski I, et al. Characterizing uveal melanoma patients with peritoneal metastases: A retrospective single-center analysis. Eur J Cancer. 2025. PMID: 39923275. doi:10.1016/j.ejca.2025.115280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。